Journal article
Efficacy of continuous treatment with astemizole (Hismanal) and terfenadine (Seldane) in ragweed pollen-induced rhinoconjunctivitis
Abstract
Astemizole (Hismanal; Janssen Pharmaceutica Inc., Mississauga, Ontario, Canada) and terfenadine (Seldane; Merrell Dow Pharmaceuticals [Canada], Inc., Concord, Ontario, Canada) were compared for clinical efficacy in a double-blind randomized trial during the ragweed pollen season. Sixty adults, with a history of ragweed-induced rhinoconjunctivitis, were matched according to sensitivity to ragweed pollen. Half took astemizole, 10 mg/day, and the …
Authors
Juniper EF; White J; Dolovich J
Journal
Journal of Allergy and Clinical Immunology, Vol. 82, No. 4, pp. 670–675
Publisher
Elsevier
Publication Date
October 1988
DOI
10.1016/0091-6749(88)90981-5
ISSN
0091-6749